KLRK1 and cancer: Membrane-bound molecules such as NKG2D ligands MHC class I-related molecule (MIC) and UL16-binding proteins (ULBPs) and Fas, which are involved in NK cells and CTL-mediated cytotoxicity against tumors, have been shown to be released as soluble forms in the sera of various cancer patients [26–30].